Peregrine Capital Management »

Cytokinetics shares owned by Peregrine Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Peregrine Capital Management from 13F filings

Historical chart of Peregrine Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Peregrine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Peregrine Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.4M 141k 52.80
2024-06-30 $7.6M 141k 54.18
2024-03-31 $8.9M 126k 70.11
2023-12-31 $11M 132k 83.49
2023-09-30 $6.0M 205k 29.46
2023-06-30 $5.9M 181k 32.62
2023-03-31 $7.0M 199k 35.19
2022-12-31 $7.3M 160k 45.82
2022-09-30 $7.2M 149k 48.45
2022-06-30 $6.9M 175k 39.29
2022-03-31 $8.1M 220k 36.81
2021-12-31 $9.9M 216k 45.58
2021-09-30 $10M 289k 35.74
2021-06-30 $8.4M 424k 19.79
2021-03-31 $10M 447k 23.26
2020-12-31 $12M 556k 20.78